|
Q4 FY2024
As of Jun 30, 2024
|
|
|---|---|
| Assets | |
| Current assets: | |
| Cash and cash equivalents | |
| Trade and other receivables | |
| R&D tax incentive receivable | |
| Prepaid expenses | |
| Total current assets | |
| Non-current assets: | |
| Investment in joint venture accounted for using the equity method | |
| Loans and advances to related parties | |
| Property, plant and equipment | |
| Right-of-use-assets | |
| Total non-current assets | |
| Total assets | |
| Liabilities | |
| Current liabilities: | |
| Borrowings and other financial liabilities | |
| Derivative financial instruments | |
| Trade and other payables | |
| Contract liabilities | |
| Lease liabilities | |
| Warrants liability | |
| Deferred consideration payable | |
| Provisions | |
| Total current liabilities | |
| Non-current liabilities: | |
| Lease liabilities | |
| Borrowings and other financial liabilities | |
| Provisions | |
| Derivative financial instruments | |
| Total non-current liabilities | |
| Total liabilities | |
| Equity: | |
| Issued capital | |
| Share-based payment reserve | |
| Foreign currency translation reserve | |
| Capital contribution reserve | |
| Accumulated losses | |
| Total deficit | |
| Total liabilities and equity |
Loading...
